Poland’s First Institutional Venture Capital Fund Dedicated to Life Science Announces First Closing At $ 42 Million

Dr. Marek Orlowski leads team of seasoned life science investment experts operating out of Warsaw to invest in promising Central and Eastern European Life Science companies

Warsaw, Poland, March 23, 2015 / B3C newswire / —  Joint Polish Investment Fund Management (JPIF) announced today the first closing of its new venture capital fund, Joined Polish Investment Fund I at $ 42 Million.

It is the first institutional venture capital fund operating out of Poland that is completely dedicated to life science investments. The fund will invest in early- and mid-stage companies with a close relationship to Poland and marks an important milestone on the country’s path to further strengthen its life science industry.

Investment activities will focus on areas with strong growth, relatively short holding periods and high return potential e.g. companies in the area of medical technology, enabling technology or mobile health.

Read press release here.
Warsaw, Poland, March 23, 2015 / B3C newswire / —  Joint Polish Investment Fund Management (JPIF) announced today the first closing of its new venture capital fund, Joined Polish Investment Fund I at $ 42 Million.

It is the first institutional venture capital fund operating out of Poland that is completely dedicated to life science investments. The fund will invest in early- and mid-stage companies with a close relationship to Poland and marks an important milestone on the country’s path to further strengthen its life science industry.

Investment activities will focus on areas with strong growth, relatively short holding periods and high return potential e.g. companies in the area of medical technology, enabling technology or mobile health.

Read press release here.